Amylyx Pharmaceuticals, Inc. AMLX
27.62 USD -1.78 (-6.05%)
At closeNov 5, 2026, 5:45 PM EST
27.53 -0.09 -0.33%
After hours · Nov 5, 5:45 PM ET
27.48 Day range 30.23
10.83 52-week range 41.14
- YTD
- +128.64%
- 1 year
- +108.61%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -153.29M | -314.73M | 38.80M | -201.34M | -82.69M | |
| -144.74M | -301.74M | 49.27M | -198.38M | -87.93M | |
| -1.53 | -4.43 | 0.70 | -3.39 | -13.35 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 227.64M | 78.84M | 170.92M | 63.24M | 50.38M | |
| 332.64M | 193.63M | 517.45M | 391.45M | 105.61M | |
| 27.39M | 28.87M | 84.02M | 50.85M | 17.43M | |
| 5.96M | 1.98M | 4.24M | 6.28M | 0 | |
| 305.26M | 164.76M | 433.43M | 340.61M | -151.17M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -123.34M | -167.65M | 11.92M | -179.87M | -74.80M | |
| 14.04M | 75.65M | 92.05M | -238.99M | -46.41M | |
| 257.03M | 348.00K | 3.54M | 431.79M | 158.51M | |
| -138.00K | -157.00K | -1.24M | -2.53M | -353.00K | |
| 148.80M | -92.08M | 107.67M | 12.87M | 37.31M |